Skip to Main Content

WASHINGTON — Progressive lawmakers are increasingly warning that they would forcefully oppose any effort to set up a system of arbitration to help lower drug prices, a model that would fall short of their demands to allow the federal government to negotiate with drug companies.

It’s an idea that has the implicit backing of House Speaker Nancy Pelosi (D-Calif.), whose top health policy aide has been focused on the proposal in talks with other experts. The speaker’s backing of any eventual legislation could put it on the fast track for congressional action, though no bill on the issue has yet been introduced in Congress.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!